Close
  • Home

CAR-T Digest - August 2020

CAR-T Digest - August 2020

CAR-T Digest - August 2020

CAR-T Digest - August 2020

Funding

Deals  ·  Weekly Digest - 06 December to 12 December 2025
Korea BNC and ProAbtek jointly develop Albubody’s dual-target next-generation ADC anticancer drug

Weekly Digest – December 2025 Weekly Digest – December 2025 05 December 2025: Korea BNC and ProAbtek jointly develop Albubody’s dual-target next-generation ADC anticancer drug Korea BNC and ProAbTech signed a joint R&D deal to develop dual-target ADCs powered by […]

by Sandhya Ramalingam

Continue Reading
Deals  ·  Weekly Digest - 06 December to 12 December 2025
Oxford BioTherapeutics enters into a strategic collaboration with GSK to discover novel targets for antibody-based therapeutics for the treatment of cancer

Weekly Digest – December 2025 Weekly Digest – December 2025 10 December 2025: Oxford BioTherapeutics enters into a strategic collaboration with GSK to discover novel targets for antibody-based therapeutics for the treatment of cancer Oxford BioTherapeutics (OBT) and GSK have […]

by Sandhya Ramalingam

Continue Reading
Approval  ·  Weekly Digest - 29 November to 05 December 2025
MHRA approves Tisotumab vedotin for the treatment of cervical cancer

Weekly Digest – December 2025 Weekly Digest – December 2025 02 December 2025: MHRA approves Tisotumab vedotin for the treatment of cervical cancer The MHRA has approved Tisotumab vedotin (Tivdak) for adults with recurrent or metastatic cervical cancer whose disease […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest - 29 November to 05 December 2025
European Medicines Agency validates Type II Variation Application for PADCEV (Enfortumab vedotin) with KEYTRUDA (Pembrolizumab) for certain patients with muscle-invasive bladder cancer

Weekly Digest – December 2025 Weekly Digest – December 2025 01 December 2025: European Medicines Agency validates Type II Variation Application for PADCEV (Enfortumab vedotin) with KEYTRUDA (Pembrolizumab) for certain patients with muscle-invasive bladder cancer The EMA has validated Astellas’ […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest - 29 November to 05 December 2025
Celltrion’s ADC anticancer drug ‘CT-P70’ receives Fast Track Designation from the US FDA

Weekly Digest – December 2025 Weekly Digest – December 2025 04 December 2025: Celltrion’s ADC anticancer drug ‘CT-P70’ receives Fast Track Designation from the US FDA  Celltrion’s ADC candidate CT-P70 has received FDA Fast Track Designation for metastatic non-squamous NSCLC […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest - 29 November to 05 December 2025
IDEAYA Biosciences announces IND clearance for IDE034, a potential first-in-class bispecific B7H3/PTK7 TOP1 ADC targeting multiple solid tumor types

Weekly Digest – December 2025 Weekly Digest – December 2025 01 December 2025: IDEAYA Biosciences announces IND clearance for IDE034, a potential first-in-class bispecific B7H3/PTK7 TOP1 ADC targeting multiple solid tumor types IDEAYA has received FDA IND clearance for IDE034, […]

by Sandhya Ramalingam

Continue Reading
Deals  ·  Weekly Digest - 29 November to 05 December 2025
Kelun-Biotech and Crescent Biopharma announce strategic partnership to develop and commercialize novel oncology therapeutics

Weekly Digest – December 2025 Weekly Digest – December 2025 04 December 2025: Kelun-Biotech and Crescent Biopharma announce strategic partnership to develop and commercialize novel oncology therapeutics Kelun-Biotech and Crescent Biopharma have entered a strategic partnership to co-develop and commercialize […]

by Sandhya Ramalingam

Continue Reading
Deals  ·  Weekly Digest - 29 November to 05 December 2025
SK Biopharm secures European actinium‑225 supply from Germany’s Eckert & Ziegler

Weekly Digest – December 2025 Weekly Digest – December 2025 03 December 2025: SK Biopharm secures European actinium‑225 supply from Germany’s Eckert & Ziegler SK Biopharm has signed an agreement with Germany’s Eckert & Ziegler to secure a reliable supply […]

by Sandhya Ramalingam

Continue Reading
Approval  ·  Weekly Digest - 22 November to 28 November 2025
U.S. FDA approves PADCEV plus Keytruda for certain patients with bladder cancer

Weekly Digest – November 2025 Weekly Digest – November 2025 25 November 2025: U.S. FDA approves PADCEV plus Keytruda for certain patients with bladder cancer  The FDA has approved PADCEV (enfortumab vedotin-ejfv) plus Keytruda as the first perioperative regimen to […]

by Sandhya Ramalingam

Continue Reading
Approval  ·  Weekly Digest - 22 November to 28 November 2025
Blenrep approved in Australia for use in adults with relapsed or refractory multiple myeloma as part of triplet combination therapy

Weekly Digest – November 2025 Weekly Digest – November 2025 24 November 2025: Blenrep approved in Australia for use in adults with relapsed or refractory multiple myeloma as part of triplet combination therapy Australia has approved Blenrep (belantamab mafodotin), a first-of-its-kind […]

by Sandhya Ramalingam

Continue Reading
« First‹ Previous272829303132333435Next ›Last »
Page 31 of 63


Contact:

  info@ciscientists.com

 +1-908-212-7484

Optimal Dose

For a subscription, please provide your email id